{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:54:29Z","timestamp":1794956069898,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Youth Foundation of Jiangsu Province of China","award":["BK20241110"],"award-info":[{"award-number":["BK20241110"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772273"],"award-info":[{"award-number":["2025M772273"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent"},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0548202"],"award-info":[{"award-number":["2025ZD0548202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05622-1","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:35:39Z","timestamp":1771662939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vericiguat in patients with acute coronary syndrome and reduced ejection fraction: the EVE-ACSrEF study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xinying","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3204-2710","authenticated-orcid":false,"given":"Sibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-6560","authenticated-orcid":false,"given":"Liansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"1","key":"5622_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10741-019-09831-z","volume":"25","author":"BR Pagliaro","year":"2020","unstructured":"Pagliaro BR, Cannata F, Stefanini GG, Bolognese L. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020;25(1):53\u201365.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"5622_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.emc.2022.06.008","volume":"40","author":"J Atwood","year":"2022","unstructured":"Atwood J. Management of acute coronary syndrome. Emerg Med Clin North Am. 2022;40(4):693\u2013706.","journal-title":"Emerg Med Clin North Am"},{"issue":"7","key":"5622_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: A review. JAMA. 2022;327(7):662\u201375.","journal-title":"JAMA"},{"issue":"10332","key":"5622_CR4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","volume":"399","author":"BA Bergmark","year":"2022","unstructured":"Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347\u201358.","journal-title":"Lancet"},{"issue":"2","key":"5622_CR5","first-page":"127","volume":"10","author":"SK Hui","year":"2021","unstructured":"Hui SK, Sharma A, Docherty K, McMurray JJV, Pitt B, Dickstein K, et al. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. Eur Heart J Acute Cardiovasc Care. 2021;10(2):127\u201331.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"5622_CR6","doi-asserted-by":"publisher","first-page":"e191938","DOI":"10.1001\/jamanetworkopen.2019.1938","volume":"2","author":"HM Krumholz","year":"2019","unstructured":"Krumholz HM, Normand ST, Wang Y. Twenty-Year trends in outcomes for older adults with acute myocardial infarction in the united States. JAMA Netw Open. 2019;2(3):e191938.","journal-title":"JAMA Netw Open"},{"issue":"9351","key":"5622_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13\u201320.","journal-title":"Lancet"},{"issue":"9","key":"5622_CR8","first-page":"e17781","volume":"13","author":"S Kansakar","year":"2021","unstructured":"Kansakar S, Guragain A, Verma D, Sharma P, Dhungana B, Bhattarai B, et al. Soluble Guanylate Cyclase Stimulators Heart Fail Cureus. 2021;13(9):e17781.","journal-title":"Soluble Guanylate Cyclase Stimulators Heart Fail Cureus"},{"issue":"2","key":"5622_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","volume":"18","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, B\u00f6hm M, et al. Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev. 2013;18(2):123\u201334.","journal-title":"Heart Fail Rev"},{"issue":"12","key":"5622_CR10","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1111\/cts.13677","volume":"16","author":"ME Trujillo","year":"2023","unstructured":"Trujillo ME, Ayalasomayajula S, Blaustein RO, Gheyas F. Vericiguat, a novel sGC stimulator: mechanism of action, clinical, and translational science. Clin Transl Sci. 2023;16(12):2458\u201366.","journal-title":"Clin Transl Sci"},{"issue":"12","key":"5622_CR11","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852\u201366.","journal-title":"Circ Res"},{"key":"5622_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.niox.2021.03.002","volume":"109\u2013110","author":"J Ye","year":"2021","unstructured":"Ye J, Dai Y, Mao H, Zheng W, Zhang J. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis. Nitric Oxide. 2021;109\u2013110:50\u20136.","journal-title":"Nitric Oxide"},{"issue":"20","key":"5622_CR13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382(20):1883\u201393.","journal-title":"N Engl J Med"},{"issue":"2","key":"5622_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ejhf.3501","volume":"27","author":"YNV Reddy","year":"2025","unstructured":"Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S, et al. Vericiguat global study in participants with chronic heart failure: design of the VICTOR trial. Eur J Heart Fail. 2025;27(2):209\u201318.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"5622_CR15","first-page":"34","volume":"109","author":"R Nohria","year":"2024","unstructured":"Nohria R, Viera AJ. Acute coronary syndrome: diagnosis and initial management. Am Fam Physician. 2024;109(1):34\u201342.","journal-title":"Am Fam Physician"},{"issue":"5","key":"5622_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2024.02.020","volume":"12","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, DeFilippis EM, Bansal K, Riello RJ 3rd, Bozkurt B, Heidenreich PA, et al. Contemporary American and European guidelines for heart failure management: JACC: heart failure guideline comparison. JACC Heart Fail. 2024;12(5):810\u201325.","journal-title":"JACC Heart Fail"},{"issue":"22","key":"5622_CR17","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.120.050850","volume":"143","author":"I Johansson","year":"2021","unstructured":"Johansson I, Joseph P, Balasubramanian K, McMurray JJV, Lund LH, Ezekowitz JA, et al. Health-Related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries. Circulation. 2021;143(22):2129\u201342.","journal-title":"Circulation"},{"key":"5622_CR18","doi-asserted-by":"publisher","first-page":"132524","DOI":"10.1016\/j.ijcard.2024.132524","volume":"417","author":"J Tian","year":"2024","unstructured":"Tian J, Dong M, Sun X, Jia X, Zhang G, Zhang Y, et al. Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: insights from a 6-month real-world study. Int J Cardiol. 2024;417:132524.","journal-title":"Int J Cardiol"},{"issue":"9","key":"5622_CR19","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.jchf.2025.102587","volume":"13","author":"JA Spertus","year":"2025","unstructured":"Spertus JA, Jones PG, Butler J, Arnold SV. Minimally important Kansas City cardiomyopathy questionnaire changes across the spectrum of heart failure severity. JACC Heart Fail. 2025;13(9):102587.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"5622_CR20","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cardfail.2023.07.004","volume":"29","author":"NP Goodwin","year":"2023","unstructured":"Goodwin NP, Clare RM, Harrington JL, Badjatiya A, Wojdyla DM, Udell JA, et al. Morbidity and mortality associated with heart failure in acute coronary syndrome: A pooled analysis of 4 clinical trials. J Card Fail. 2023;29(12):1603\u201314.","journal-title":"J Card Fail"},{"key":"5622_CR21","doi-asserted-by":"crossref","unstructured":"Saldarriaga CI, Zannad F, McMullan CJ, Xing A, Gates D, Anstrom KJ et al. Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: the VICTOR trial. Eur J Heart Fail. 2025;27(8):1426\u201335.","DOI":"10.1002\/ejhf.3598"},{"issue":"6","key":"5622_CR22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.recesp.2021.11.027","volume":"75","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022;75(6):523.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"18","key":"5622_CR23","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"3","key":"5622_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.26599\/1671-5411.2025.03.002","volume":"22","author":"SY Zhang","year":"2025","unstructured":"Zhang SY. Chinese guidelines for the diagnosis and treatment of heart failure 2024. J Geriatr Cardiol. 2025;22(3):277\u2013331.","journal-title":"J Geriatr Cardiol"},{"issue":"10510","key":"5622_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0140-6736(25)01682-4","volume":"406","author":"F Zannad","year":"2025","unstructured":"Zannad F, O\u2019Connor CM, Butler J, McMullan CJ, Anstrom KJ, Barash I, et al. Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. Lancet. 2025;406(10510):1351\u201362.","journal-title":"Lancet"},{"issue":"10","key":"5622_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/clc.22745","volume":"40","author":"RV Jeger","year":"2017","unstructured":"Jeger RV, Pfister O, Radovanovic D, Eberli FR, Rickli H, Urban P, et al. Heart failure in patients admitted for acute coronary syndromes: A report from a large National registry. Clin Cardiol. 2017;40(10):907\u201313.","journal-title":"Clin Cardiol"},{"issue":"4","key":"5622_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.amjcard.2006.03.023","volume":"98","author":"A Segev","year":"2006","unstructured":"Segev A, Strauss BH, Tan M, Mendelsohn AA, Lai K, Ashton T, et al. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian acute coronary syndrome Registries). Am J Cardiol. 2006;98(4):470\u20133.","journal-title":"Am J Cardiol"},{"issue":"2","key":"5622_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00395-016-0540-y","volume":"111","author":"JS Bice","year":"2016","unstructured":"Bice JS, Jones BR, Chamberlain GR, Baxter GF. Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: a systematic review of experimental and clinical studies. Basic Res Cardiol. 2016;111(2):23.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"5622_CR29","first-page":"228","volume":"2014","author":"A Gehani","year":"2014","unstructured":"Gehani A, Al-Suwaidi J, Yacoub M, NIAMI. Towards the optimization of results in primary PCI. Glob Cardiol Sci Pract. 2014;2014(3):228\u201331.","journal-title":"Glob Cardiol Sci Pract"},{"key":"5622_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1479-5876-11-116","volume":"11","author":"N Siddiqi","year":"2013","unstructured":"Siddiqi N, Bruce M, Neil CJ, Jagpal B, Maclennon G, Cotton SC, et al. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI). J Transl Med. 2013;11:116.","journal-title":"J Transl Med"},{"issue":"19","key":"5622_CR31","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/eurheartj\/ehu096","volume":"35","author":"N Siddiqi","year":"2014","unstructured":"Siddiqi N, Neil C, Bruce M, MacLennan G, Cotton S, Papadopoulou S, et al. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J. 2014;35(19):1255\u201362.","journal-title":"Eur Heart J"},{"issue":"4","key":"5622_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/eurheartj\/ehu313","volume":"36","author":"J Takahashi","year":"2015","unstructured":"Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2015;36(4):228\u201337.","journal-title":"Eur Heart J"},{"key":"5622_CR33","doi-asserted-by":"crossref","unstructured":"Ho EC, Parker JD, Austin PC, Tu JV, Wang X, Lee DS. Impact of nitrate use on survival in acute heart failure: A Propensity-Matched analysis. J Am Heart Assoc. 2016;5(2):e002531.","DOI":"10.1161\/JAHA.115.002531"},{"issue":"1","key":"5622_CR34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1159\/000541393","volume":"14","author":"C Lavalle","year":"2024","unstructured":"Lavalle C, Mariani MV, Severino P, Palombi M, Trivigno S, D\u2019Amato A, et al. Efficacy of modern therapies for heart failure with reduced ejection fraction in specific population subgroups: A systematic review and network Meta-Analysis. Cardiorenal Med. 2024;14(1):570\u201380.","journal-title":"Cardiorenal Med"},{"issue":"12","key":"5622_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.21037\/atm-22-2583","volume":"10","author":"Y Cai","year":"2022","unstructured":"Cai Y, Zhang B, Shalamu A, Gao T, Ge J. Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation. Ann Transl Med. 2022;10(12):662.","journal-title":"Ann Transl Med"},{"issue":"11","key":"5622_CR36","doi-asserted-by":"publisher","first-page":"e44481","DOI":"10.1371\/journal.pone.0044481","volume":"7","author":"JC Irvine","year":"2012","unstructured":"Irvine JC, Ganthavee V, Love JE, Alexander AE, Horowitz JD, Stasch JP, et al. The soluble Guanylyl cyclase activator Bay 58-2667 selectively limits cardiomyocyte hypertrophy. PLoS ONE. 2012;7(11):e44481.","journal-title":"PLoS ONE"},{"issue":"7","key":"5622_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/hr.2009.64","volume":"32","author":"H Masuyama","year":"2009","unstructured":"Masuyama H, Tsuruda T, Sekita Y, Hatakeyama K, Imamura T, Kato J, et al. Pressure-independent effects of Pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart. Hypertens Res. 2009;32(7):597\u2013603.","journal-title":"Hypertens Res"},{"issue":"9","key":"5622_CR38","doi-asserted-by":"publisher","first-page":"15314","DOI":"10.3390\/molecules190915314","volume":"19","author":"MS Fran\u00e7a-Silva","year":"2014","unstructured":"Fran\u00e7a-Silva MS, Balarini CM, Cruz JC, Khan BA, Rampelotto PH, Braga VA. Organic nitrates: past, present and future. Molecules. 2014;19(9):15314\u201323.","journal-title":"Molecules"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05622-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05622-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05622-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:08:58Z","timestamp":1774616938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05622-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5622"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05622-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Approval No. 2023-SR-731).The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}